Molecular characteristics and clinicopathology of CTNNB1-mutated endometrial cancer: Implications for fertility-sparing management in young women.

doi:10.1186/s12885-026-16370-y

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Molecular characteristics and clinicopathology of CTNNB1-mutated endometrial cancer: Implications for fertility-sparing management in young women.

BMC cancer - 17 Jun 2026

Li Wen-Qi, Wu Hai-Xia, Li Han-Bo, Shuai Guang-Nan, Zhang Qing, Shen Yan

Abstract excerpt

BACKGROUND: The incidence rate of endometrial cancer (EC) is increasing among young women who require fertility preservation. The identification of molecular biomarkers can improve clinical outcomes in these patients. This study evaluated the role of CTNNB1 mutations in EC and whether the CTNNB1 gene can serve as a molecular marker in fertility-sparing management. METHODS: Retrospective cohorts of patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Biomarkers, Tumor
Share to Endometrial Neoplasms
Share to CTNNB1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to FST gene

Share to Immunohistochemistry

Share to Mutation

Share to Progestins

Source

Open in PubMed Open full text

Identifiers

PMID: 42310566
DOI: 10.1186/s12885-026-16370-y
PMCID: PMC13508427

Genes

CTNNB1
FST

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.